MedTrace Logo

Clinical Efficacy of Self-adhesive Silicone Gel Waterproof Dressings Versus Conventional Dressings in the Healing of Incisions After Total Joint Arthroplasty

NCT06467721 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2024-06-21

No results posted yet for this study

Summary

The efficacy of using self-adhesive silicone gel waterproof dressings versus conventional gauze dressings for recovery after total joint arthroplasty (TJA) remains unclear. In our study, we conducted a prospective, randomized controlled trial to compare these two types of dressings. Patients were divided into two groups following TJA, and we collected primary outcome measures such as skin infection rate and re-operation rate. Additionally, we gathered blood inflammatory indicators, including C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), to evaluate the effectiveness of the two treatments. Finally, we perform one year follow up including REEDA score, MSS score to evaluate the recovery of the skin.

Conditions

  • Self-adhesive Silicone Gel Waterproof Dressing
  • Gauze Dressing
  • Total Joint Arthroplasty

Interventions

DEVICE

Self-adhesive silicone gel waterproof dressing

Self-adhesive silicone gel waterproof dressing is used after artificial joint replacement surgery.

DEVICE

Sterile gauze dressing

Sterile gauze dressing is used after artificial joint replacement surgery.

Sponsors & Collaborators

  • First Affiliated Hospital of Xinjiang Medical University

    lead OTHER

Principal Investigators

  • Li Cao · The first affliated hospital, Xinjiang medical university

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2025-12-31
Completion
2026-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06467721 on ClinicalTrials.gov